Pain Therapeutics, Inc. (PTIE) Forms $4.24 Double Bottom; Last Week McKesson (MCK) Coverage

December 9, 2017 - By Kurt Siggers

Among 21 analysts covering McKesson Corporation (NYSE:MCK), 10 have Buy rating, 1 Sell and 10 Hold. Therefore 48% are positive. McKesson Corporation had 71 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Buy” rating by Goldman Sachs given on Wednesday, November 4. The firm has “Hold” rating given on Tuesday, April 4 by Needham. Mizuho maintained the stock with “Buy” rating in Monday, January 18 report. The stock of McKesson Corporation (NYSE:MCK) has “Buy” rating given on Thursday, October 26 by Robert W. Baird. Leerink Swann maintained the stock with “Hold” rating in Monday, April 24 report. The stock of McKesson Corporation (NYSE:MCK) earned “Neutral” rating by Mizuho on Tuesday, June 7. The firm has “Outperform” rating given on Tuesday, January 12 by FBR Capital. The company was maintained on Tuesday, August 29 by Jefferies. The stock of McKesson Corporation (NYSE:MCK) earned “Buy” rating by Needham on Monday, October 16. Robert W. Baird upgraded McKesson Corporation (NYSE:MCK) on Tuesday, September 19 to “Outperform” rating. See McKesson Corporation (NYSE:MCK) latest ratings:

04/12/2017 Broker: Deutsche Bank Rating: Buy New Target: $175 Initiates Coverage On
09/11/2017 Broker: Credit Suisse Rating: Sell New Target: $130.0 Maintain
01/11/2017 Broker: Needham Rating: Buy Old Target: $178.00 New Target: $173.00 Maintain
30/10/2017 Broker: Needham Rating: Buy New Target: $173.0 Maintain
26/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $183.0 Maintain
24/10/2017 Broker: Mizuho Rating: Hold New Target: $168.0 Maintain
24/10/2017 Broker: Needham Rating: Buy New Target: $178.0 Maintain
18/10/2017 Broker: Jefferies Rating: Hold New Target: $165.0 Maintain
16/10/2017 Broker: Needham Rating: Buy New Target: $179.0 Maintain
10/10/2017 Broker: Cowen & Co Old Rating: Market Perform New Rating: Outperform Upgrade

Pain Therapeutics, Inc. (PTIE) formed double bottom with $3.99 target or 6.00% below today’s $4.24 share price. Pain Therapeutics, Inc. (PTIE) has $27.97 million valuation. The stock increased 4.69% or $0.19 during the last trading session, reaching $4.24. About 82,433 shares traded. Pain Therapeutics, Inc. (NASDAQ:PTIE) has declined 72.83% since December 9, 2016 and is downtrending. It has underperformed by 89.53% the S&P500.

The stock increased 1.71% or $2.56 during the last trading session, reaching $152.57. About 1.40M shares traded. McKesson Corporation (NYSE:MCK) has declined 15.45% since December 9, 2016 and is downtrending. It has underperformed by 32.15% the S&P500.

Investors sentiment decreased to 0.95 in Q2 2017. Its down 0.02, from 0.97 in 2017Q1. It dropped, as 66 investors sold McKesson Corporation shares while 305 reduced holdings. 100 funds opened positions while 253 raised stakes. 176.11 million shares or 4.62% less from 184.63 million shares in 2017Q1 were reported. Manning Napier Advsrs invested 0.03% in McKesson Corporation (NYSE:MCK). 1832 Asset Mgmt L P invested in 14,608 shares or 0.01% of the stock. Mirae Asset Glob stated it has 0.03% in McKesson Corporation (NYSE:MCK). Thomas Story & Son Ltd Co holds 0.15% or 1,500 shares in its portfolio. Andra Ap reported 0.09% stake. Hugh Johnson Advsr Llc reported 0.52% of its portfolio in McKesson Corporation (NYSE:MCK). Westpac invested in 0% or 19,566 shares. 3,974 are held by Everence. Brandes Investment Partners Limited Partnership owns 979,257 shares for 2.55% of their portfolio. Moreover, Security National has 0.05% invested in McKesson Corporation (NYSE:MCK) for 887 shares. 4,400 are held by Spirit Of America Mngmt. Ruffer Llp accumulated 1.32 million shares. Glenmede Trust Na has 0.05% invested in McKesson Corporation (NYSE:MCK). Oregon Pub Employees Retirement Fund owns 85,740 shares for 0.24% of their portfolio. Tocqueville Asset Management Lp accumulated 0.01% or 5,344 shares.

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company has market cap of $31.81 billion. The firm operates in two divisions, McKesson Distribution Solutions and McKesson Technology Solutions. It has a 7.23 P/E ratio. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community oncology and other specialty practices.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com